The pharmaceutical value chain model depicted in Figure 1 covers a full range of activities that are required to bring a product from conception to final consumer. The key players in the chain are ...
Biotechnology companies can use “value-chain analysis” to create processes for maximizing the value of their intellectual property portfolios, say Bill Barrett and Dave Crawford. Every ...
The paper pushes back against pessimism that agriculture cannot play an effective role in climate change mitigation and adaptation because of its fragmented nature. Structures and incentives within ...
The Union cabinet in September approved the fourth OSAT plant in the country, with Kaynes Semicon receiving the go-ahead for its chip assembly and packaging unit.